How much revenue does FluoGuide A/S make?

FluoGuide A/S reported 0 DKK in revenue for fiscal year 2025.

What companies are similar to FluoGuide A/S?

Listed companies of a similar size in the same industry (targeted healthcare equipment) include Episurf Medical AB (publ) (EPIS-B.ST), C-Rad AB (publ) (CRAD-B.ST), Bactiguard Holding AB (publ) (BACTI-B.ST), Senzime AB (publ) (SEZI.ST).

FluoGuide A/S (FLUO.ST) Stock

About FluoGuide A/S

FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in Phase II clinical trial for the treatment of high-grade glioma and lung, head, and neck cancer; and functions as a photosensitizer, which is in pre-clinical stage for the treatment...

At a glance

FluoGuide A/S reported revenue of 0 DKK for fiscal year 2025, and net income of -39.46 million DKK.

Figures from company filings; latest fiscal year ended December 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.